Gene Therapy for Age-related Macular Degeneration Market Report

China Gene Therapy for Age-related Macular Degeneration Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：190
  • REPORT CODE：GMM1757902
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Gene Therapy for Age-related Macular Degeneration industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AGTC

    • REGENXBIO

    By Type:

    • Subretinal

    • Unspecified

    • Intravitreal

    By Application:

    • Monotherapy

    • Combination Therapy

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Gene Therapy for Age-related Macular Degeneration Market Overview 2018-2029

    • 1.1 China Gene Therapy for Age-related Macular Degeneration Industry Development Overview

    • 1.2 China Gene Therapy for Age-related Macular Degeneration Industry Development History

    • 1.3 China Gene Therapy for Age-related Macular Degeneration Industry Market Size (2018-2029)

    • 1.4 China Gene Therapy for Age-related Macular Degeneration Market Analysis by Type from Production Side

      • 1.4.1 China Gene Therapy for Age-related Macular Degeneration Production Volume, Production Value and Growth Rate of Subretinal (2018-2029)

      • 1.4.2 China Gene Therapy for Age-related Macular Degeneration Production Volume, Production Value and Growth Rate of Unspecified (2018-2029)

      • 1.4.3 China Gene Therapy for Age-related Macular Degeneration Production Volume, Production Value and Growth Rate of Intravitreal (2018-2029)

    • 1.5 China Gene Therapy for Age-related Macular Degeneration Market Analysis by Application from Consumption End

      • 1.5.1 China Gene Therapy for Age-related Macular Degeneration Sales Volume, Sales Value and Growth Rate of Monotherapy (2018-2029)

      • 1.5.2 China Gene Therapy for Age-related Macular Degeneration Sales Volume, Sales Value and Growth Rate of Combination Therapy (2018-2029)

    • 1.6 China Gene Therapy for Age-related Macular Degeneration Market Analysis by Region

      • 1.6.1 North China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    Chapter 2 China Gene Therapy for Age-related Macular Degeneration Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Gene Therapy for Age-related Macular Degeneration Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Gene Therapy for Age-related Macular Degeneration Market Status and Competition Analysis in 2023

      • 2.2.3 China Gene Therapy for Age-related Macular Degeneration Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Gene Therapy for Age-related Macular Degeneration Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Gene Therapy for Age-related Macular Degeneration Industry Development

    Chapter 3 Gene Therapy for Age-related Macular DegenerationIndustry Chain Analysis

    • 3.1 Gene Therapy for Age-related Macular Degeneration Industry Chain

    • 3.2 Gene Therapy for Age-related Macular Degeneration Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Gene Therapy for Age-related Macular Degeneration Market

    • 3.3 Gene Therapy for Age-related Macular Degeneration Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Gene Therapy for Age-related Macular Degeneration Market

    Chapter 4 China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 4.1 China Gene Therapy for Age-related Macular Degeneration Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Gene Therapy for Age-related Macular Degeneration Total Production Volume and Growth Rate from Production Side

    • 4.5 China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate, by Type

      • 4.5.1 China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate of Subretinal

      • 4.5.2 China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate of Unspecified

      • 4.5.3 China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate of Intravitreal

    Chapter 5 China Gene Therapy for Age-related Macular Degeneration Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Gene Therapy for Age-related Macular Degeneration Total Market Size and Growth Rate from Consumption End

    • 5.5 China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate, by Application

      • 5.5.1 China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate of Monotherapy

      • 5.5.2 China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate of Combination Therapy

    Chapter 6 China Gene Therapy for Age-related Macular Degeneration Market, by Region

    • 6.1 China Gene Therapy for Age-related Macular Degeneration Production Volume and Production Value, by Region

    • 6.2 China Gene Therapy for Age-related Macular Degeneration Sales Volume and Sales Value, by Region

    Chapter 7 North China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 7.1 North China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 7.2 North China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 8 Central China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 8.1 Central China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 8.2 Central China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 9 South China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 9.1 South China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 9.2 South China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 10 East China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 10.1 East China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 10.2 East China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 11 Northeast China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 11.1 Northeast China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 11.2 Northeast China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 12 Southwest China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 12.1 Southwest China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 12.2 Southwest China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 13 Northwest China Gene Therapy for Age-related Macular Degeneration Market Analysis

    • 13.1 Northwest China Gene Therapy for Age-related Macular Degeneration Market, by Type

    • 13.2 Northwest China Gene Therapy for Age-related Macular Degeneration Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AGTC

        • 14.1.1 AGTC Company Profile

        • 14.1.2 AGTC Gene Therapy for Age-related Macular Degeneration Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 REGENXBIO

        • 14.2.1 REGENXBIO Company Profile

        • 14.2.2 REGENXBIO Gene Therapy for Age-related Macular Degeneration Market Performance

        • 14.2.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Gene Therapy for Age-related Macular Degeneration Industry Research Conclusions

    • 15.2 Gene Therapy for Age-related Macular Degeneration Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Gene Therapy for Age-related Macular Degeneration Industry Market Size (2018-2029)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume, Production Value and Growth Rate of Subretinal (2018-2029)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume, Production Value and Growth Rate of Unspecified (2018-2029)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume, Production Value and Growth Rate of Intravitreal (2018-2029)

    • Figure China Gene Therapy for Age-related Macular Degeneration Sales Volume, Sales Value and Growth Rate of Monotherapy (2018-2029)

    • Figure China Gene Therapy for Age-related Macular Degeneration Sales Volume, Sales Value and Growth Rate of Combination Therapy (2018-2029)

    • Figure North China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure Central China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure South China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure East China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate from 2018-2029

    • Figure Gene Therapy for Age-related Macular Degeneration Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Gene Therapy for Age-related Macular Degeneration Market Share by Type in 2018

    • Figure China Gene Therapy for Age-related Macular Degeneration Market Share by Type in 2023

    • Figure China Gene Therapy for Age-related Macular Degeneration Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate of Subretinal (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate of Unspecified (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume and Growth Rate of Intravitreal (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Market Share by Application in 2018

    • Figure China Gene Therapy for Age-related Macular Degeneration Market Share by Application in 2023

    • Figure China Gene Therapy for Age-related Macular Degeneration Total Market Size and Growth Rate from Consumption End

    • Figure China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate of Monotherapy (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Market Size and Growth Rate of Combination Therapy (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Production Volume by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Region (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Production Value by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Production Value Share by Region (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Production Value Share by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Sales Volume by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Region (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Sales Value by Region (2018-2023)

    • Table China Gene Therapy for Age-related Macular Degeneration Sales Value Share by Region (2018-2023)

    • Figure China Gene Therapy for Age-related Macular Degeneration Sales Value Share by Region (2018-2023)

    • Table North China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table North China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure North China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table North China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table North China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure North China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table Central China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table Central China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure Central China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table Central China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table Central China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure Central China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table South China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table South China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure South China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table South China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table South China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure South China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table East China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table East China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure East China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table East China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table East China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure East China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table Northeast China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table Northeast China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure Northeast China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table Northeast China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table Northeast China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table Southwest China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table Southwest China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure Southwest China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table Southwest China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table Southwest China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table Northwest China Gene Therapy for Age-related Macular Degeneration Production Volume by Type (2018-2023)

    • Table Northwest China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Figure Northwest China Gene Therapy for Age-related Macular Degeneration Production Volume Share by Type (2018-2023)

    • Table Northwest China Gene Therapy for Age-related Macular Degeneration Sales Volume by Application (2018-2023)

    • Table Northwest China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Gene Therapy for Age-related Macular Degeneration Sales Volume Share by Application (2018-2023)

    • Table AGTC Company Profile

    • Table AGTC Gene Therapy for Age-related Macular Degeneration Revenue, Price and Gross (2018-2023)

    • Table REGENXBIO Company Profile

    • Table REGENXBIO Gene Therapy for Age-related Macular Degeneration Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US